Airija - anglų - HPRA (Health Products Regulatory Authority)

abbvie limited - ribavirin - film coated tablet - 400 milligram - ribavirin

Airija - anglų - HPRA (Health Products Regulatory Authority)

abbvie limited - ribavirin - film coated tablet - 600 milligram - ribavirin

Airija - anglų - HPRA (Health Products Regulatory Authority)

abbvie limited - ribavirin - film coated tablet - 200 milligram - ribavirin

Malta - anglų - Malta Medicines Authority

abbvie limited citywest business campus, dublin 24, ireland - sevoflurane - inhalation gas - sevoflurane 100 % (v/v) - anesthetics

Airija - anglų - HPRA (Health Products Regulatory Authority)

abbvie limited - epinastine hydrochloride - eye drops, solution - other antiallergics; epinastine

Naujoji Zelandija - anglų - Medsafe (Medicines Safety Authority)

abbvie limited - leuprorelin acetate 3.75mg (powder for injection compartment) - injection (depot) - 3.75 mg - active: leuprorelin acetate 3.75mg (powder for injection compartment) excipient: acetic acid carmellose sodium gelatin plga (copoly (dl-lactic acid/glycolic acid) 75:25mol%) powder for injection compartment mannitol polysorbate 80 water for injection - lucrin (leuprorelin acetate) is indicated · in metastatic prostate cancer · in locally advanced prostate cancer, as an alternative to surgical castration · as an adjuvant treatment to radiotherapy in patients with high-risk localized or locally advanced prostate cancer · as an adjuvant treatment to radical prostatectomy in patients with locally advanced prostate cancer at high risk of disease progression

Naujoji Zelandija - anglų - Medsafe (Medicines Safety Authority)

abbvie limited - leuprorelin acetate 11.25mg (powder for injection compartment) - injection (depot) - 11.25 mg - active: leuprorelin acetate 11.25mg (powder for injection compartment) excipient: carmellose sodium glacial acetic acid polylactic acid (pla) powder for injection compartment mannitol polysorbate 80 water for injection - lucrin (leuprorelin acetate) is indicated · in metastatic prostate cancer · in locally advanced prostate cancer, as an alternative to surgical castration · as an adjuvant treatment to radiotherapy in patients with high-risk localized or locally advanced prostate cancer · as an adjuvant treatment to radical prostatectomy in patients with locally advanced prostate cancer at high risk of disease progression

Naujoji Zelandija - anglų - Medsafe (Medicines Safety Authority)

abbvie limited - palivizumab 100mg (;+overage = 122mg/vial) - injection with diluent - 100 mg - active: palivizumab 100mg (;+overage = 122mg/vial) excipient: glycine histidine mannitol nitrogen transferrin water for injection - synagis is indicated for the prevention of serious lower respiratory tract disease caused by respiratory syncytial virus (rsv) in children at high risk of rsv disease. safety and efficacy were established in children with bronchopulmonary dysplasia (bpd), infants with a history of prematurity (gestational age < 35 weeks at birth) and children with haemodynamically significant congenital heart disease (chd).

Naujoji Zelandija - anglų - Medsafe (Medicines Safety Authority)

abbvie limited - palivizumab 50mg (;+ overage = 73mg/vial) - injection with diluent - 50 mg - active: palivizumab 50mg (;+ overage = 73mg/vial) excipient: glycine histidine mannitol nitrogen water for injection - synagis is indicated for the prevention of serious lower respiratory tract disease caused by respiratory syncytial virus (rsv) in children at high risk of rsv disease. safety and efficacy were established in children with bronchopulmonary dysplasia (bpd), infants with a history of prematurity (gestational age < 35 weeks at birth) and children with haemodynamically significant congenital heart disease (chd).

Airija - anglų - HPRA (Health Products Regulatory Authority)

abbvie limited - brimonidine tartrate; timolol maleate - eye drops, solution - beta blocking agents1); timolol, combinations